Antibiotics During Intrauterine Balloon Tamponade Placement
Obstetric Complication, Postpartum Hemorrhage, Postpartum Endometritis
About this trial
This is an interventional prevention trial for Obstetric Complication focused on measuring Bakri, Intrauterine balloon tamponade, Antibiotics
Eligibility Criteria
Inclusion Criteria:
- Female
- Able to give consent
- Gestational age > 24 weeks
- Postpartum
- Placement of an IBT within the last 2 hours with plans for it to remain in situ for at least 2 hours
- Primary obstetrician amenable to proceeding with either method of management during the study period.
Exclusion Criteria:
- Age < 18 years old
- IBT removed within 2 hours of placement
- Chorioamnionitis
- Insufficient documentation of demographics, delivery outcomes, or peripartum events including postpartum hemorrhage, infectious outcomes
Sites / Locations
- Cedars-Sinai Medical Center
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Antibiotics
The patient will not receive antibiotics as part of the study, though if at any time her provider chooses to administer antibiotics either prophylactically or for treatment she will not prohibited in any way from this or any other treatment as appropriate.
The patient will receive a 24-hour course of antibiotics. The primary antibiotic of choice will be cefazolin 1 gm iv q8 hours. If the patient has contraindications to the use of cefazolin including cefazolin allergy, hypersensitivity, or severe beta lactam allergy, then clindamycin 900 mg iv q8 hours will be used instead.